Asterias Biotherapeutics
NYSEAMERICAN:ASTAsterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.
ATI
NYSE:ATIATI Inc. produces and sells specialty materials and complex components worldwide. It operates in two segments: High Performance Materials & Components (HPMC) and Advanced Alloys & Solutions (AA&S). The HPMC segment produces various materials, including titanium and titanium-based alloys, nickel- and cobalt-based alloys and superalloys, metallic powder alloys, advanced powder alloys and other specialty materials, in long product forms, such as ingot, billet, bar, rod, wire, shapes and rectangles, and seamless tubes, as well as precision forgings, components, and machined parts. The AA&S segment produces zirconium and related alloys, including hafnium and niobium, nickel-based alloys, titanium and titanium-based alloys, and specialty alloys in a variety of forms, such as plate, sheet, and precision rolled strip products. It also provides hot-rolling conversion services, including carbon steel products. ATI Inc. serves to aerospace and defense, energy, automotive, construction and mining, food equipment and appliances, and medical markets. The company was formerly known as Allegheny Technologies Incorporated. ATI Inc. was incorporated in 1996 and is headquartered in Dallas, Texas.
International Frontier Resources
CVE:IFRInternational Frontier Resources Corporation acquires, develops, exploits, and produces oil and natural gas in Mexico. The company has oil and natural gas interests in the Central Mackenzie Valley, Northwest Territories, Canada; and owns mineral titles covering an area of 15,200 acres located in Northwest Montana. The company has a strategic alliance with SIMMONS EDECO to pursue oil and gas operations in the Mexican market primarily focused on upstream oil and gas, as well as midstream and service contract opportunities. The company was founded in 1995 and is headquartered in Calgary, Canada.
New Stratus Energy
CVE:NSENew Stratus Energy Inc. engages in the acquisition, exploration, and development of oil and gas properties principally in Latin America. It has a farm-in agreement to acquire 100% interests in Block VMM-18 located in Cuenca Valle Medio del Magdalena, Colombia; and operates Blocks 16 and 67 oil consortiums located in Ecuador. The company was formerly known as Red Rock Energy Inc. and changed its name to New Stratus Energy Inc. in August 2017. New Stratus Energy Inc. was incorporated in 2005 and is based in Calgary, Canada.
Resolute Resources
CVE:RRLResolute Resources Ltd., an energy company, engages in the exploration and development of crude oil from shallow cretaceous sandstone reservoirs utilizing multi-lateral drilling technology in Northeast British Columbia and Northwest Alberta. The company was incorporated in 2019 and is based in Calgary, Canada.